Capricor Therapeutics Cash Flow Statement (2011-2025) | CAPR

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating Activities
Net Income (Quarter)	-5.15M	-5.07M	-4.30M	-6.36M	-7.82M	-7.30M	-6.37M	-7.69M	-7.77M	-7.37M	-6.39M	-0.83M	-9.79M	-11.00M	-12.56M	-7.01M	-24.25M	-25.93M	-24.57M	-27.13M
Depreciation and Depletion (Quarter)	0.05M	0.05M	0.06M	0.08M	0.09M	0.11M	0.14M	0.19M	0.23M	0.25M	0.28M	0.31M	0.33M	0.36M	0.36M	0.38M	0.41M	0.49M	0.49M	0.50M
Share-based Compensation (Quarter)	0.75M	0.71M	0.72M	0.78M	1.07M	1.16M	1.09M	1.15M	2.19M	1.62M	1.72M	1.86M	3.27M	2.15M	2.05M	2.30M	5.48M	-5.22M	12.87M	3.84M
Gains from Investment Securities (Quarter)	3.67M	3.62M	1.64M	0.05M		2.56M	2.64M		1.76M	1.82M	1.26M	0.00M	0.03M	10.59M	0.46M	-0.31M
Non-cash Items (Quarter)	8.08M	1.26M	8.50M	3.10M	12.40M	12.70M	2.26M	10.10M	3.09M	3.43M	14.40M	4.25M	5.00M	5.52M	16.60M	101.79M
Cash from Operations (Quarter)	-3.33M	-4.51M	-3.34M	-5.63M	24.05M	-6.54M	-5.69M	-6.90M	4.21M	-9.42M	-8.79M	-11.59M	-1.27M	-12.29M	-11.64M	-14.80M	-6.43M	-20.12M	-19.69M	-23.57M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter)
Depreciation & Amortization (CF) (Quarter)	0.05M	0.05M	0.06M	0.08M	0.09M	0.11M	0.14M	0.19M	0.23M	0.25M	0.28M	0.31M	0.33M	0.36M	0.36M	0.38M	0.41M	0.49M	0.49M	0.50M
Change in Working Capital
Change in Account Payables (Quarter)
Change in Accured Expenses (Quarter)	0.43M	-0.35M	-0.31M	0.63M	-0.02M	0.04M	-0.53M	2.23M	0.50M	-0.29M	1.66M	-0.54M	-0.00M	-0.08M	0.36M	1.66M	1.32M	1.53M	0.97M	2.17M
Other Working Capital Changes (Quarter)	0.03M	0.10M	0.15M	0.88M	0.05M	0.09M	0.39M	-28.65M	0.11M	0.46M	0.69M	1.17M	-4.91M	0.24M	0.41M	-1.13M	0.03M	-0.23M	0.97M	3.33M
Investing Activities
Capital Expenditures (Quarter)	0.04M	0.32M	0.47M	0.37M	0.57M	0.18M	0.56M	0.69M	0.35M	0.14M	0.27M	0.56M	0.61M	0.06M	0.01M	0.49M	0.90M	0.29M	0.06M	1.66M
Change in Intangibles (Quarter)
Divestments (Quarter)
Change in Acquisitions & Divestments (Quarter)						14.01M	30.09M	38.41M	32.05M	24.75M	28.16M	19.64M	24.37M	30.85M	21.86M	16.72M	43.21M	76.00M	78.18M	63.21M
Cash from Investing Activities (Quarter)	-0.04M	-0.32M	-0.47M	-0.37M	-0.63M	-35.41M	-4.18M	5.14M	-3.21M	6.46M	7.72M	-5.86M	-9.50M	14.70M	2.00M	-123.38M	23.89M	14.55M	15.95M	43.09M
Financing Activities
Other financing activities (Quarter)	0.75M	0.71M	0.72M	0.78M	1.07M	1.16M	1.09M	1.15M	2.19M	1.62M	1.72M	1.86M	3.27M	2.15M	2.05M	2.30M
Cash from Financing Activities (Quarter)	12.58M	1.04M	6.57M	0.04M	0.03M	0.02M	1.88M	2.95M	0.00M	2.19M	0.22M	23.17M	2.29M	2.07M	67.33M	81.09M	0.05M	0.02M	0.01M	248.82M
Additional items
Change in Cash (Quarter)	9.21M	-3.80M	2.76M	-5.95M	23.45M	-41.94M	-7.98M	1.19M	1.00M	-0.77M	-0.85M	5.71M	-8.48M	4.47M	57.69M	-57.09M	17.51M	-5.55M	-3.73M	268.34M
Free Cash Flow (Quarter)	-3.37M	-4.84M	-3.81M	-6.00M	23.48M	-6.72M	-6.24M	-7.60M	3.86M	-9.55M	-9.06M	-12.15M	-1.88M	-12.35M	-11.65M	-15.29M	-7.33M	-20.41M	-19.74M	-25.23M
Net Cash Flow (Quarter)	9.21M	-3.80M	2.76M	-5.95M	23.45M	-41.94M	-7.98M	1.19M	1.00M	-0.77M	-0.85M	5.71M	-8.48M	4.47M	57.69M	-57.09M	17.51M	-5.55M	-3.73M	268.34M

Research Tools

Capricor Therapeutics Cash Flow Statement (2011-2025) | CAPR

Create an account

Sign In

Reset Password